NCT06285708

Brief Summary

The long-term goal of this study is to reduce suicidal thoughts and behaviors among treatment-seeking individuals who also have posttraumatic stress disorder (PTSD). Prolonged exposure (PE) and crisis response plan (CRP) have demonstrated empirical support for reducing suicide attempts as compared to treatment as usual. However, no studies to date have assessed their effectiveness when used in combination. In light of this knowledge gap, the primary objective of this study will be to test the effectiveness of PE augmented with CRP as compared to PE with care as usual (self-guided treatment plan), an active comparator, for the reduction of suicide ideations and attempts for individuals with comorbid PTSD.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

February 26, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

July 5, 2024

Status Verified

July 1, 2024

Enrollment Period

1.3 years

First QC Date

February 14, 2024

Last Update Submit

July 3, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Beck Scale for Suicidal Ideation (SSI)

    19 item self-report assessment of suicidal ideation, range of scores is 0-57, higher score indicates higher suicidal ideation

    During the first 3 weeks and through one year follow up

  • Self-Injurious Thoughts and Behaviors Interview-Revised (SITBI-R)

    31 item self-report measure of suicidal thoughts and behavior

    During the first 3 weeks and through one year follow up

  • PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5)

    20 item self-report measure that assesses the 20 DSM-5 symptoms of PTSD. range is 0-80, higher score indicates higher PTSD symptoms

    During the first 3 weeks and through one year follow up

Secondary Outcomes (15)

  • Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Self-Rated Level 1 Cross-Cutting Symptom Measure

    During the first 3 weeks and through one year follow up

  • Interpersonal Needs Questionnaire (INQ) - Abbreviated

    During the first 3 weeks and through one year follow up

  • Beck Hopelessness Scale (BHS) - Abbreviated

    During the first 3 weeks and through one year follow up

  • Brief Suicide Cognitions Scale (SCS)

    During the first 3 weeks and through one year follow up

  • Difficulties in Emotion Regulation Scale-Short Form (DERS-SF)

    During the first 3 weeks and through one year follow up

  • +10 more secondary outcomes

Study Arms (2)

Prolonged exposure with crisis response plan

EXPERIMENTAL

In the enhanced prolonged exposure condition, participants will complete a CRP instead of a safety plan. The CRP is another recommended standard care practice with suicidal patients that includes many of the same elements as the safety plan (i.e., warning signs, self-management strategies, sources of social support, crisis services), but is created collaboratively by the patient with active input of their clinician rather than being self-guided. The CRP also includes a section focused on the participant's reasons for living, an addition that has been shown to increase positive emotional states (e.g., hope, optimism) and lead to faster reductions in suicidal intent. The CRP will be administered during the first therapy session.

Behavioral: Prolonged exposure

Prolonged exposure with safety plan

ACTIVE COMPARATOR

In the standard prolonged exposure condition, participants will complete a safety plan, a procedure that includes personal warning signs for a suicidal crisis, self-management strategies, sources of social support, and contact information for professional resources and crisis services within the participant's local community, as well as the National Suicide Prevention Lifeline phone number. As a recommended standard care practice with suicidal patients, the combination of PE and safety plan represents treatment as usual. The safety plan will be administered during the first therapy session.

Behavioral: Prolonged exposure

Interventions

PE therapy is a manualized cognitive behavioral therapy consisting of imaginal exposure (repeated recounting of the most disturbing traumatic memory) followed by processing thoughts and feelings related to the imaginal experience; in-vivo exposure (approaching trauma-related situations); psychoeducation about PTSD; and controlled breathing training. Between sessions, participants listen to audio recordings of the imaginal recounting daily and complete in-vivo exercises. Typically, PE is delivered weekly for 10-12, 90-minutes sessions. For this study, participants will complete daily 60-minute sessions for 10 consecutive weekdays during a 2-week period.

Prolonged exposure with crisis response planProlonged exposure with safety plan

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current diagnosis of PTSD or subthreshold PTSD; ability to speak and understand the English language; and ability to complete the informed consent process.

You may not qualify if:

  • Substance use disorder requiring medical management; imminent suicide risk warranting inpatient hospitalization or suicide-focused treatment; and impaired mental status that precludes the ability to provide informed consent (e.g., intoxication, psychosis, mania).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSuicidal IdeationSuicide, AttemptedPsychological Trauma

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Jaryd Hiser, Ph.D.

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jaryd Hiser, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2024

First Posted

February 29, 2024

Study Start

February 26, 2024

Primary Completion

July 1, 2025

Study Completion

January 1, 2026

Last Updated

July 5, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Individual participant data available by request

Locations